XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Unallocated Common Stock Held by the Employee Stock Ownership Plan
Unallocated Common Stock Held by the Employee Stock Ownership Plan
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (loss) Net of tax
Accumulated Other Comprehensive Income (loss) Net of tax
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balance (in shares) at Dec. 31, 2018       49,635,673                        
Beginning Balance at Dec. 31, 2018 $ 666,439     $ 609   $ 546,219   $ (20,992)   $ 302,544     $ (9,147)   $ (152,794)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 40,235                 40,235            
Other comprehensive (loss) income, net of tax 13,846                       13,846      
ESOP shares allocated or committed to be released 2,340         1,088   1,252                
Stock compensation expense 3,236         3,236                    
Net forfeitures of restricted stock (in shares)       (8,000)                        
Net forfeitures of restricted stock 0         118                 (118)  
Exercise of stock options (in shares)       583,574                        
Exercise of stock options, net 5,770         (2,175)                 7,945  
Cash dividends declared (20,198)                 (20,198)            
Treasury stock (in shares)       (1,035,900)                        
Treasury stock (15,815)                           (15,815)  
Ending Balance (in shares) at Dec. 31, 2019       49,175,347                        
Ending Balance at Dec. 31, 2019 $ 695,853     $ 609   548,486   (19,740)   322,581     4,699   (160,782)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13                              
Net income $ 36,988                 36,988            
Other comprehensive (loss) income, net of tax 8,461                       8,461      
ESOP shares allocated or committed to be released 1,780         569   1,211                
Stock compensation expense 1,432         1,432                    
Net issuance of restricted stock (in shares)       83,744                        
Net issuance of restricted stock 0         (1,145)                 1,145  
Net forfeitures of restricted stock (in shares)       (3,573)                        
Net forfeitures of restricted stock $ 0         34                 (34)  
Exercise of stock options (in shares) 13,000     13,000                        
Exercise of stock options, net $ 175         (4)                 179  
Cash dividends declared (21,476)                 (21,476)            
Issuance of stock for VSB Bancorp, Inc. acquisition (in shares)       3,837,168                        
Issuance of stock for VSB Bancorp, Inc. acquisition 41,173     $ 39   41,134                    
Treasury stock (in shares)       (3,342,700)                        
Treasury stock (10,405)                           (53,321)  
Ending Balance (in shares) at Dec. 31, 2020       52,209,897 52,209,897                      
Ending Balance at Dec. 31, 2020 753,981 $ (3,087) $ 750,894 $ 648 $ 648 590,506 $ 590,506 (18,529) $ (18,529) 338,093 $ (3,087) $ 335,006 13,160 $ 13,160 (169,897) $ (169,897)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 70,654                 70,654            
Other comprehensive (loss) income, net of tax (11,097)                       (11,097)      
ESOP shares allocated or committed to be released 2,649         1,178   1,471                
Stock compensation expense 994         994                    
Net issuance of restricted stock (in shares)       147,315                        
Net issuance of restricted stock 0         (1,821)                 1,821  
Net forfeitures of restricted stock (in shares)       (13,280)                        
Net forfeitures of restricted stock $ 0         178                 (178)  
Exercise of stock options (in shares) 394,045     265,501                        
Exercise of stock options, net $ 3,409         (1,063)                 4,472  
Cash dividends declared (24,299)                 (24,299)            
Treasury stock (53,321)                              
Ending Balance (in shares) at Dec. 31, 2021       49,266,733                        
Ending Balance at Dec. 31, 2021 $ 739,883     $ 648   $ 589,972   $ (17,058)   $ 381,361     $ 2,063   $ (217,103)